missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Human LRRK2 [D1994A], GST Tag Recombinant Protein

Recombinant Protein

2880.00 - 13560.00

Specificatie

Concentratie See Label
Voor gebruik met (toepassing) Kinase Assay
Formulering proprietary buffer with no preservative
Moleculair gewicht 205 kDa
Naam Human LRRK2 [D1994A], GST Tag
Meer specificaties weergeven

Producten 2
Produktcode Merk Aantal Prijs Hoeveelheid en beschikbaarheid  
Produktcode Merk Aantal Prijs Hoeveelheid en beschikbaarheid  
15448713
Bekijk documenten
Invitrogen™
PR9102A
100 μg
2880.00
100 µg
Please to purchase this item. Need a web account? Register with us today!
15498803
Bekijk documenten
Invitrogen™
PV6052
1 mg
13560.00
1 mg
Please to purchase this item. Need a web account? Register with us today!
Beschrijving

Beschrijving

LRRK2 is a multidomain protein that includes a kinase domain, a GTPase domain, and a leucine-rich repeat (LRR) domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in LRRK2 (R1441C Mutant) have been associated with Parkinson disease-8.
Specificatie

Specificatie

See Label
proprietary buffer with no preservative
Human LRRK2 [D1994A], GST Tag
LRRK2 (D1994A Mutant)
970-2527; D1994A
Human
GST-tag
Baculovirus
Kinase Assay
205 kDa
RUO - research use only
LRRK Kinase Family
Unconjugated
Recombinant
-80°C, Avoid Freeze/Thaw Cycles
Liquid
Video's
SDS
Documentatie

Documentatie

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.